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Résumé en
anglais
Plasmid DNA (pDNA) and small interfering RNAs (siRNAs) are very useful tools for
the treatment of cancer. However, pDNA and siRNAs efficacy is restricted by their
negative charge and susceptibility to degradation by endonucleases that prevent
them penetrating tissue and cellular barriers such as the plasma and endolysosomal
membranes. Viral vectors have some advantages but their use is largely limited by
their immunogenicity. On the other hand, synthetic nanoparticles have advantage of
being relatively non-immunogenic but their ability to deliver nucleic acids remains
less efficient than their viral counterparts. The present study is focussed on the
development and evaluation of biomimetic lipid nanocapsules (LNCs) functionalized
with a L1 papillomavirus type-16 capsid-derived lipopeptide on their surface, for
transfection of U87MG glioma cells and Caco-2 colorectal adenocarcinoma cells
with pDNA or siRNAs. Since the L1-peptide has been described as a nuclear
localization signal able to complex with nucleic acids and bind to heparan sulfate on
the cell surface, the structure and function of L1-peptide bound to LNCs (L1-LNCs)
were investigated. Although L1-LNCs were shown to complex with both pDNA and
siRNAs, the pDNA-L1-LNC complexes showed only weak transfection efficiency. In
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